Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Director, President and CEO · CareDx, Inc. · Common Stock
Open-market sale
$214K reported value · 1.6% of prior position
Disclosed 3 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | KEITH S KENNEDYCFO & COO | Option exercise · 10b5-1 plan | M | — 52.4K sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 16 | KEITH S KENNEDYCFO & COO | Option exercise · 10b5-1 plan | M | $1.54M 52.4K sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $118K 1,505 sh | Nov 9, 2026 traded Nov 6, 2026 | |
| 15 | KEITH S KENNEDYCFO & COO | Open-market sale · 10b5-1 plan | SELL | $958K 12.4K sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 11 | KEITH S KENNEDYCFO & COO | Open-market sale · 10b5-1 plan | SELL | $542K 6,897 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 11 | KEITH S KENNEDYCFO & COO | Open-market sale · 10b5-1 plan | SELL | $589K 7,415 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 11 | KEITH S KENNEDYCFO & COO | Open-market sale · 10b5-1 plan | SELL | $274K 3,403 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 8 | KEITH S KENNEDYCFO & COO | Open-market sale · 10b5-1 plan | SELL | $221K 2,710 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 5 | KEITH S KENNEDYCFO & COO | Open-market sale · 10b5-1 plan | SELL | $25K 300 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 8 | KEITH S KENNEDYCFO & COO | Open-market sale · 10b5-1 plan | SELL | $50K 600 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 18 | KEITH S KENNEDYCFO & COO | Open-market sale · 10b5-1 plan | SELL | $2.16M 28.3K sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 20 | Cohen Fred EDirector | Gift | G | — 25.0K sh | Nov 4, 2026 traded Nov 3, 2026 | |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $247K 2,873 sh | Nov 3, 2026 traded Nov 1, 2026 | |
| 8 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $66K 997 sh | Oct 5, 2026 traded Oct 1, 2026 | |
| 12 | Meng JessicaChief Commercial Officer | Tax withholding | F | $173K 2,619 sh | Oct 5, 2026 traded Oct 1, 2026 | |
| 15 | Meng JessicaChief Commercial Officer | Tax withholding | F | $350K 6,688 sh | Sep 15, 2026 traded Sep 12, 2026 | |
| 5 | Novack Jeffrey AdamSecretary and General Counsel | Tax withholding | F | $29K 997 sh | Jul 2, 2026 traded Jul 1, 2026 | |
| 12 | Meng JessicaChief Commercial Officer | Tax withholding | F | $71K 2,411 sh | Jul 2, 2026 traded Jul 1, 2026 | |
| 5 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | $5,789 706 sh | Jun 30, 2026 traded Jun 4, 2026 | |
| 0 | Hanna John Walter JRDirector, President and CEO | Option exercise · 10b5-1 plan | M | — 39.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $213,804
Hanna John Walter JR filed this Form 4 reporting a open-market sale of CDNA on Jan 15, 2026. It became public on Jan 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.